Shany E, Saada A, Landau D, Shaag A, Hershkovitz E, Elpeleg O N
Neonatology and Pediatric Departments, Soroka Medical Center, Beer-Sheva, Israel.
Biochem Biophys Res Commun. 1999 Aug 19;262(1):163-6. doi: 10.1006/bbrc.1999.1133.
An infant with a neurodegenerative disorder accompanied by lactic acidemia is described. In muscle homogenate, the activity of lipoamide dehydrogenase (LAD), the third catalytic subunit of pyruvate dehydrogenase complex (PDHc), alpha-ketoglutarate dehydrogenase complex (KGDHc), and branched-chain keto acid dehydrogenase complex was reduced to 15% of the control. The activity of PDHc was undetectable and the activity of KGDHc was 2% of the control mean. The immunoreactive LAD protein was reduced to about 10% of the control. Direct sequencing of LAD cDNA revealed only one mutation, substituting Asp for Val at position 479 of the precursor form. The mutation resides within the interface domain and likely perturbs stable dimerization. The phenotypic heterogeneity in LAD deficiency is not directly correlated with the residual LAD activity but rather with its impact on the multienzymatic complex activity.
本文描述了一名患有神经退行性疾病并伴有乳酸性血症的婴儿。在肌肉匀浆中,丙酮酸脱氢酶复合体(PDHc)、α-酮戊二酸脱氢酶复合体(KGDHc)和支链酮酸脱氢酶复合体的第三个催化亚基硫辛酰胺脱氢酶(LAD)的活性降至对照组的15%。PDHc的活性无法检测到,KGDHc的活性为对照组平均值的2%。免疫反应性LAD蛋白降至对照组的约10%。LAD cDNA的直接测序仅发现一个突变,在前体形式的第479位将天冬氨酸替换为缬氨酸。该突变位于界面结构域内,可能会扰乱稳定的二聚化。LAD缺乏症的表型异质性与残余LAD活性没有直接相关性,而是与其对多酶复合体活性的影响有关。